Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

sell
Stoke Therapeutics Inc

Start price
Target price
Perf. (%)
€5.80
18.03.24
-
18.03.25
94.83%
28.03.24

quelbe60 
18.03.24 50%
sell
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.51
18.03.24
-
18.03.25
2.26%
28.03.24

quelbe60 
18.03.24 50%
buy
Verastem Inc.

Start price
Target price
Perf. (%)
€10.20
18.03.24
-
18.03.25
8.82%
28.03.24

quelbe60 
18.03.24 50%
buy
Gritstone Oncology Inc

Start price
Target price
Perf. (%)
€2.16
18.03.24
-
18.03.25
-26.96%
31.03.24

Global_Player 
18.03.24 50%
buy
Viking Therapeutics Inc

Start price
Target price
Perf. (%)
€59.00
17.03.24
-
17.03.25
24.64%
26.03.24

michaelkr 
17.03.24 50%
buy
TG Therapeutics Inc.

Start price
Target price
Perf. (%)
€14.18
17.03.24
-
17.03.25
-1.78%
30.03.24

michaelkr 
17.03.24 50%
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€134.80
17.03.24
-
17.04.24
0.48%
18.04.24

AlexM84 
17.03.24 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€26.20
17.03.24
-
17.04.24
0.50%
18.04.24

Alowa 
17.03.24 50%
sell
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.51
17.03.24
€0.30
30.11.25
76.96%
28.03.24

Could be very worthwhile Investment >20% year
BiotechBee 
17.03.24 60%
sell
Stoke Therapeutics Inc

Start price
Target price
Perf. (%)
€5.80
17.03.24
€3.00
31.01.26
60.34%
25.03.24

Could be very worthwhile Investment >20% year
BiotechBee 
17.03.24 60%
buy
Inventiva SA

Start price
Target price
Perf. (%)
€3.71
17.03.24
€5.00
31.01.26
-2.70%
19.03.24

Could be very worthwhile Investment >20% year
BiotechBee 
17.03.24 50%
buy
Verastem Inc.

Start price
Target price
Perf. (%)
€10.20
17.03.24
€16.00
30.06.26
-8.82%
19.03.24

Could be very worthwhile Investment >20% year
BiotechBee 
17.03.24 60%
buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€10.75
17.03.24
-
17.03.25
-28.39%
17.04.24

RudolfL 
17.03.24 0%
buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€14.50
16.03.24
€20.00
16.03.25
-8.28%
25.03.24

WatchMen 
16.03.24 50%
sell
Oncopeptides AB

Start price
Target price
Perf. (%)
€0.37
16.03.24
-
16.03.25
49.61%
27.03.24

WatchMen 
16.03.24 50%
sell
Syros Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€5.40
16.03.24
€20.00
05.02.25
9.26%
25.03.24

WatchMen 
16.03.24 0%
buy
Ocular Therapeutix Inc.

Start price
Target price
Perf. (%)
€5.53
16.03.24
-
-
16.03.24

WatchMen 
16.03.24 50%
buy
Applied Therapeutics Inc

Start price
Target price
Perf. (%)
€5.39
16.03.24
€10.00
16.03.25
-12.47%
15.04.24

WatchMen 
16.03.24 50%
buy
Gritstone Oncology Inc

Start price
Target price
Perf. (%)
€2.16
16.03.24
€6.00
16.03.25
-29.70%
02.04.24

WatchMen 
16.03.24 50%
sell
Atara Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€0.56
16.03.24
€6.00
05.02.25
21.30%
28.03.24

WatchMen 
16.03.24 0%
buy
Fibrogen Inc.

Start price
Target price
Perf. (%)
€2.12
16.03.24
€6.00
16.03.25
-24.55%
04.04.24

WatchMen 
16.03.24 50%
sell
Madrigal Pharmaceuticals inc.

Start price
Target price
Perf. (%)
€251.90
16.03.24
€120.00
16.03.25
-3.22%
30.03.24

nvestor 
16.03.24 50%
buy
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.51
16.03.24
€2.00
16.03.25
2.26%
30.03.24

Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Low dividend yield expected
mixitrader 
16.03.24 50%
buy
Chromadex Corp

Start price
Target price
Perf. (%)
€2.22
16.03.24
€4.00
16.03.25
53.15%
30.03.24

EBIT decline/stagnation expected
Revenue decline/stagnation expected
High valuation
Low dividend yield expected
mixitrader 
16.03.24 50%
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€4.89
16.03.24
€48.00
16.03.25
-12.06%
30.03.24

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Rising EBIT margin expected
Low dividend yield expected
mixitrader 
16.03.24 50%